Jeffrey L. Masten

2013

In 2013, Jeffrey L. Masten earned a total compensation of $684.9K as Former Vice President, Quality at Peregrine Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$97,256
Option Awards$193,410
Salary$296,181
Other$98,045
Total$684,892

Masten received $296.2K in salary, accounting for 43% of the total pay in 2013.

Masten also received $97.3K in non-equity incentive plan, $193.4K in option awards and $98K in other compensation.

Rankings

In 2013, Jeffrey L. Masten's compensation ranked 8,225th out of 12,286 executives tracked by ExecPay. In other words, Masten earned more than 33.1% of executives.

ClassificationRankingPercentile
All
8,225
out of 12,286
33rd
Division
Manufacturing
2,980
out of 4,612
35th
Major group
Chemicals And Allied Products
931
out of 1,462
36th
Industry group
Drugs
706
out of 1,156
39th
Industry
Pharmaceutical Preparations
558
out of 890
37th
Source: SEC filing on August 28, 2014.

Masten's colleagues

We found five more compensation records of executives who worked with Jeffrey L. Masten at Peregrine Pharmaceuticals in 2013.

2013

Steven King

Peregrine Pharmaceuticals

Chief Executive Officer

2013

Paul Lytle

Peregrine Pharmaceuticals

Chief Financial Officer

2013

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

2013

Shelley Fussey

Peregrine Pharmaceuticals

Vice President, Intellectual Property

2013

Joseph Shan

Peregrine Pharmaceuticals

Vice President, Clinical & Regulatory Affairs

You may also like